NeoGenomics Q2 Revenues Rise on Genetic Test Volume Growth

This article has been updated to include comments from NeoGenomics' earnings call.

NEW YORK (GenomeWeb) – NeoGenomics today reported year over year growth of 159 percent in its second quarter revenues driven by an increase in clinical genetic testing volume. 

For the three-month period ended June 30, the company posted revenues of $63.1 million compared with $24.4 million a year earlier.